Indeed, here here. As manufacturing capacity ramps up, and cost approaches $1-$5/month/person, it is an antidote against an economy wired to profit off of miswired reward centers. Success is comin'. Healthier humans, less spending on poor nutrition, lower healthcare costs and improved health at scale. There is even robust evidence that GLP-1 agonists reduce addictive consumption of alcohol, nicotine, and opioids [1] [2].

It's the next metformin imho (cost to benefit ratio). We should be scaling up production like it's a war effort.

[1] https://news.ycombinator.com/item?id=40558601 (citation)

[2] https://news.ycombinator.com/item?id=40357197 ("u/comova: 1. GLP-1 drugs appear to dramatically reduce addictive drive across substances. 2. GLP-1 drugs can reach vastly more patients than existing medications and they have positive mental health benefits for anxiety and depression. 3. This is our first ever opportunity to make a big dent in the addiction crisis, which kills 770,000 people a year between opioids, cigarettes, and alcohol.")